These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2159273)

  • 1. Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
    Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
    Arch Pharm (Weinheim); 1990 Feb; 323(2):121-4. PubMed ID: 2159273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
    Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
    J Cancer Res Clin Oncol; 1989; 115(2):161-5. PubMed ID: 2715167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes.
    Hartmann RW; Buchborn H; Kranzfelder G; Schönenberger H; Bogden A
    J Med Chem; 1981 Oct; 24(10):1192-7. PubMed ID: 6276542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.
    Kranzfelder G; Hartmann RW; von Angerer E; Schönenberger H; Bogden AE
    J Cancer Res Clin Oncol; 1982; 103(2):165-80. PubMed ID: 6284766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.
    Schuderer ML; Schneider MR
    J Cancer Res Clin Oncol; 1987; 113(3):230-4. PubMed ID: 3584214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
    von Angerer E; Erber S
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer drugs: estrophilic cisplatin derivatives.
    Engel J; Schönenberger H; Lux F; Hilgard P
    Cancer Treat Rev; 1987 Dec; 14(3-4):275-83. PubMed ID: 2830970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat.
    Hartmann RW; Schönenberger H; Wrobel KH
    J Cancer Res Clin Oncol; 1982; 103(3):241-54. PubMed ID: 6288725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of derivatisation of the hydroxy groups in 1,1-bis-(4-hydroxyphenyl)-2-phenylbut-1-ene on estradiol receptor affinity and mammary tumor inhibiting properties.
    Schuderer ML; Schneider MR
    Arch Pharm (Weinheim); 1987 Jul; 320(7):635-41. PubMed ID: 3675160
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes.
    Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H
    J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.
    Zablocki JA; Katzenellenbogen JA; Carlson KE; Norman MJ; Katzenellenbogen BS
    J Med Chem; 1987 May; 30(5):829-38. PubMed ID: 3033242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain.
    Landvatter SW; Katzenellenbogen JA
    J Med Chem; 1982 Nov; 25(11):1300-7. PubMed ID: 6292423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
    Hartmann RW; Heindl A; Schönenberger H
    J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
    Hartmann RW
    J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting properties.
    Schertl S; Gust R; Müller R; Spruss T; Schönenberger H
    Arch Pharm (Weinheim); 1992 Feb; 325(2):113-8. PubMed ID: 1605715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.